Article: Getting Gene Therapy into the Fast Lane
Summary: In this article published by The Medicine Maker, Catalent expert George Buchman, Ph.D., Research Fellow, Catalent Cell and Gene Therapy, discusses the recent increase in gene therapy approvals and how we can accelerate the manufacturing speed with platform processes.
KEY LEARNINGS:
- Gene therapy approvals have increased in 2023
- Creating a platform approach for AAV
- How we can ramp up manufacturing speed on the road to commercialization